NYSE:HLN Haleon (HLN) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free HLN Stock Alerts $8.54 +0.12 (+1.43%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$8.39▼$8.5450-Day Range$8.03▼$8.6552-Week Range$7.70▼$9.05Volume5.45 million shsAverage Volume5.58 million shsMarket Capitalization$39.41 billionP/E Ratio30.48Dividend Yield2.46%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Haleon alerts: Email Address Haleon MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.45% of Float Sold ShortDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews Sentiment0.54Based on 6 Articles This WeekInsider TradingN/AProj. Earnings Growth8.51%From $0.47 to $0.51 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.28 out of 5 starsMedical Sector455th out of 939 stocksToilet Preparations Industry8th out of 15 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Haleon. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.45% of the float of Haleon has been sold short.Short Interest Ratio / Days to CoverHaleon has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Haleon has recently increased by 45.32%, indicating that investor sentiment is decreasing significantly. Previous Next 2.5 Dividend Strength Dividend YieldHaleon pays a meaningful dividend of 2.52%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHaleon has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of Haleon is 75.00%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Haleon will have a dividend payout ratio of 41.18% next year. This indicates that Haleon will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HLN. Previous Next 2.5 News and Social Media Coverage News SentimentHaleon has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Haleon this week, compared to 2 articles on an average week.Search Interest15 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 114% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Haleon insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 6.67% of the stock of Haleon is held by institutions. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Haleon are expected to grow by 8.51% in the coming year, from $0.47 to $0.51 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Haleon is 30.48, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.56.Price to Earnings Ratio vs. SectorThe P/E ratio of Haleon is 30.48, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 255.57.Price to Earnings Growth RatioHaleon has a PEG Ratio of 2.19. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHaleon has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Haleon Stock (NYSE:HLN)Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.Read More HLN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HLN Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comHaleon (NYSE:HLN) Given Buy Rating at ArgusMarch 19, 2024 | msn.comStocks Making Big Moves TodayMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 19, 2024 | markets.businessinsider.comHaleon Announces Pricing And Upsize Of Secondary Offering By Pfizer At $7.85/ADSMarch 18, 2024 | msn.comPfizer to Offload Haleon Shares Worth $2.5BMarch 18, 2024 | msn.comPfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2BMarch 18, 2024 | msn.comLondon's FTSE 100 opens higher on miners' boostMarch 18, 2024 | markets.businessinsider.comPfizer Plans To Sell About 630 Mln Haleon SharesMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 18, 2024 | reuters.comConsumer healthcare giant Haleon says Pfizer to cut stake to 24%March 11, 2024 | uk.finance.yahoo.comFTSE 100 Live 11 March: Currys bidder walks away, shares steady as Nikkei reverses on GDP surpriseMarch 10, 2024 | finance.yahoo.comIncome Investors Should Know That Haleon plc (LON:HLN) Goes Ex-Dividend SoonMarch 3, 2024 | finance.yahoo.comHaleon (LON:HLN) Is Increasing Its Dividend To £0.042March 2, 2024 | finance.yahoo.comHaleon Full Year 2023 Earnings: EPS Misses ExpectationsMarch 1, 2024 | seekingalpha.comHaleon plc (HLN) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | msn.comSensodyne-maker Haleon jumps on share buyback, falling debtFebruary 29, 2024 | msn.comAdvil Maker Haleon Expects Higher 2024 Revenue After Strong 2023 Earnings, Stock SoarsFebruary 29, 2024 | seekingalpha.comHaleon plc 2023 Q4 - Results - Earnings Call PresentationFebruary 29, 2024 | bloomberg.comHaleon Says Revenue Growth Accelerated at End of Last YearFebruary 28, 2024 | msn.comReckitt's quarterly sales disappoint after investigation into Middle East businessFebruary 19, 2024 | finance.yahoo.comZoetis Inc. (ZTS)February 14, 2024 | theglobeandmail.com1 Pharma Stock to Buy Near 52-Week HighsFebruary 12, 2024 | seekingalpha.comHaleon plc: Leveraging On Brand Investment And Debt ReductionFebruary 6, 2024 | finance.yahoo.comAbreva Drops One-of-a-Kind Pair of Diamond Lips, Inspired by the Cold Sore ExperienceFebruary 2, 2024 | reuters.comJudge certifies class action challenging ChapStick 'all natural' labelsJanuary 16, 2024 | msn.comGSK to sell 3.2% stake in spin-off Haleon in its third stake sale in under a yearJanuary 16, 2024 | reuters.comGSK to sell 3.2% stake in spin-off HaleonSee More Headlines Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 5/16 Dividend3/14/2024Today3/27/2024Next Earnings (Estimated)5/01/2024Dividend Payable5/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Toilet preparations Sub-IndustryN/A Current SymbolNYSE:HLN CUSIPN/A CIK1900304 Webwww.haleon.com Phone44-19-3282-2000FaxN/AEmployees25,408Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.28 Trailing P/E Ratio30.46 Forward P/E Ratio18.15 P/E Growth2.19Net Income$1.30 billion Net Margins9.28% Pretax Margin14.40% Return on Equity12.55% Return on Assets6.13% Debt Debt-to-Equity Ratio0.53 Current Ratio1.04 Quick Ratio0.73 Sales & Book Value Annual Sales$14.05 billion Price / Sales2.80 Cash Flow$0.37 per share Price / Cash Flow23.05 Book Value$4.51 per share Price / Book1.89Miscellaneous Outstanding Shares4,617,290,000Free FloatN/AMarket Cap$39.39 billion OptionableNot Optionable Beta0.30 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Brian James McNamara (Age 58)CEO & Executive Director Comp: $2.97MMr. Tobias Hannes Hestler (Age 52)CFO & Executive Director Comp: $1.26MMs. Sonya Ghobrial (Age 50)Head of Investor Relations Mr. Bjarne Philip Tellmann (Age 57)General Counsel Ms. Tamara Rogers (Age 54)Chief Marketing Officer Ms. Mairead Nayager (Age 49)Chief Human Resources Officer Mr. Filippo LanziPresident of EMEA & LatAmMr. Keith Choy (Age 55)President of Asia Pacific Ms. Lisa Paley (Age 57)President of North America Mr. Franck Riot (Age 56)Chief R&D Officer More ExecutivesKey CompetitorsGE HealthCare TechnologiesNASDAQ:GEHCAlconNYSE:ALCModernaNASDAQ:MRNACenteneNYSE:CNCHumanaNYSE:HUMView All CompetitorsInstitutional OwnershipHighPoint Advisor Group LLCBought 64,328 shares on 3/26/2024Ownership: 0.001%PNC Financial Services Group Inc.Sold 2,194 shares on 3/22/2024Ownership: 0.005%Ariston Services GroupBought 20,897 shares on 3/21/2024Ownership: 0.000%B. Riley Wealth Advisors Inc.Sold 5,519 shares on 3/15/2024Ownership: 0.001%Sivia Capital Partners LLCBought 11,317 shares on 3/13/2024Ownership: 0.000%View All Institutional Transactions Should I Buy Haleon Stock? HLN Pros and Cons Explained These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Haleon was last updated on Monday, March 25, 2024 at 11:30 AM. Pros Here are some ways that investors could benefit from investing in Haleon plc: Haleon plc engages in the research, development, manufacture, and sale of various consumer healthcare products globally, providing a diversified revenue stream. The company offers a portfolio of well-known brands like Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum, which have strong market presence and consumer trust. Haleon plc recently announced a semi-annual dividend with a yield of 1.8%, indicating a commitment to rewarding shareholders. The company's stock price has shown stability and growth potential, with a 52-week low of $7.70 and a 52-week high of $9.05, reflecting positive market performance. Haleon plc has a market capitalization of $38.05 billion, indicating a sizable presence in the consumer healthcare industry. Cons Investors should be bearish about investing in Haleon plc for these reasons: The company's P/E ratio of 29.95 and P/E/G ratio of 2.62 may suggest the stock is currently overvalued, potentially limiting short-term gains for investors. Haleon plc's debt-to-equity ratio of 0.53 indicates a moderate level of financial leverage, which could pose risks in times of economic downturns or rising interest rates. The company's recent stock performance, trading down to $8.24 during mid-day trading, may raise concerns about short-term volatility and market sentiment. While Haleon plc operates globally, exposure to multiple regions could subject the company to geopolitical risks, regulatory challenges, and currency fluctuations. Investors should consider the competitive landscape in the consumer healthcare industry, as Haleon plc faces competition from other established players and potential disruptors in the market. HLN Stock Analysis - Frequently Asked Questions Should I buy or sell Haleon stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HLN shares. View HLN analyst ratings or view top-rated stocks. How have HLN shares performed in 2024? Haleon's stock was trading at $8.23 at the beginning of 2024. Since then, HLN shares have increased by 3.7% and is now trading at $8.5350. View the best growth stocks for 2024 here. Are investors shorting Haleon? Haleon saw a increase in short interest in March. As of March 15th, there was short interest totaling 20,810,000 shares, an increase of 45.3% from the February 29th total of 14,320,000 shares. Based on an average daily trading volume, of 5,360,000 shares, the days-to-cover ratio is presently 3.9 days. Approximately 0.5% of the shares of the company are sold short. View Haleon's Short Interest. When is Haleon's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our HLN earnings forecast. How often does Haleon pay dividends? What is the dividend yield for Haleon? Haleon declared a semi-annual dividend on Thursday, February 29th. Shareholders of record on Friday, March 15th will be given a dividend of $0.1064 per share on Thursday, May 16th. This represents a yield of 1.8%. The ex-dividend date is Thursday, March 14th. Read our dividend analysis for HLN. Is Haleon a good dividend stock? Haleon (NYSE:HLN) pays an annual dividend of $0.21 per share and currently has a dividend yield of 2.52%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 75.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HLN will have a dividend payout ratio of 41.18% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for HLN. What ETFs hold Haleon's stock? ETFs with the largest weight of Haleon (NYSE:HLN) stock in their portfolio include VanEck Pharmaceutical ETF (PPH), Pacer BioThreat Strategy ETF (VIRS), ClearBridge Focus Value ESG ETF (CFCV), Horizon Kinetics Medical ETF (MEDX), Who are Haleon's major shareholders? Haleon's stock is owned by a number of retail and institutional investors. Top institutional investors include Dodge & Cox (2.40%), Clearbridge Investments LLC (0.58%), Harding Loevner LP (0.48%), Fisher Asset Management LLC (0.32%), Fisher Asset Management LLC (0.32%) and Wellington Management Group LLP (0.29%). How do I buy shares of Haleon? Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:HLN) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.